Daiichi says US FDA approves combo hypertension pill

WASHINGTON, Sept 27 (Reuters) - Japanese drugmaker Daiichi Sankyo (4568.T) said on Thursday the U.S. Food and Drug Administration approved its new pill for high blood pressure, which combines ingredients from two drugs already on the market. The pill, which will be promoted in the U.S. with the help of U.S. drugmaker Forest Laboratories Inc (FRX.N), is called Azor and combines chemicals from Daiichi's Benicar and Pfizer Inc's Norvasc, the Japanese company said.

((Reporting by Kim Dixon, Editing by Derek Caney; Reuters Messaging; kim.dixon.reuters.com@reuters.net; email; kim.dixon@reuters.com, 1-202 354 5848)) Keywords: DAIICHI HYPERTENSION/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWAT008173